Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles

被引:59
作者
Agueros, Maite [1 ]
Areses, Paloma [2 ]
Angel Campanero, Miguel [1 ]
Salman, Hesham [1 ]
Quincoces, Gemma [2 ]
Penuelas, Ivan [2 ]
Manuel Irache, Juan [1 ]
机构
[1] Univ Navarra, Dept Pharm & Pharmaceut Technol, Pamplona 31008, Spain
[2] Univ Navarra, Radiopharm Unit, Dept Nucl Med, Univ Navarra Clin, Pamplona 31008, Spain
关键词
Nanoparticles; Cyclodextrin; Bioadhesion; Gantrez (R) AN; Poly(anhydride); Oral; Tc-99m-radiostudies; BLOCK-COPOLYMER MICELLES; ORAL INSULIN DELIVERY; IMMUNOADJUVANT PROPERTIES; GASTROINTESTINAL-TRACT; PVM/MA NANOPARTICLES; BETA-CYCLODEXTRIN; LIPOPHILIC DRUGS; CARRIER SYSTEMS; QUANTIFICATION; CYCLOSPORINE;
D O I
10.1016/j.ejps.2009.02.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This work describes the preparation, characterization and evaluation of the nanoparticles formed by the copolymer of methyl vinyl ether and maleic anhydride (Gantrez (R) AN) and cyclodextrins. including beta-cyclodextrin (CD) hydroxypropyl-beta-cyclodextrin (HPCD) and 6-monodeoxy-6-monoamino-beta-cyclodextrin (NHCD). The cyclodextrin-poly(anhydride) nanoparticles were prepared by a solvent displacement method and characterized by measuring the size, zeta potential, morphology and composition. For bioadhesion studies. nanoparticles were fluorescently labelled with rhodamine B isothiocianate (RBITC). For in vivo imaging biodistribution studies, Tc-99m-labelled nanoparticles were used. Nanoparticles displayed a size of about 150 Full and a cyclodextrin content which was found optimal under the following experimental conditions: cyclodextrin/poly(anhydride) ratio of 0.25 by weight, 30 min of incubation time between the cyclodextrin and the polymer. Moreover, the oligosaccharide content was higher with CD than with NHCD and HPCD. Overall, cyclodextrin-poly(anhydride) nanoparticles displayed homogeneous bioadhesive interactions within the gut. The intensity of these interactions was higher than for control nanoparticles. The high bioadhesive capacity was observed for HPCD-NP and NHCD-NP which can be related with their rough morphology and, thus, a higher specific surface than for smooth nanoparticles (CD-NP). Finally, from in vivo studies, no evidence of translocation Of distribution to other organs was observed when these nanoparticles were orally administered. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:231 / 240
页数:10
相关论文
共 48 条
  • [11] Combined poly(isobutylcyanoacrylate) and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs
    da Silveira, AM
    Ponchel, G
    Puisieux, F
    Duchêne, D
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (07) : 1051 - 1055
  • [12] NEW APPROACH FOR ORAL-ADMINISTRATION OF INSULIN WITH POLYALKYLCYANOACRYLATE NANOCAPSULES AS DRUG CARRIER
    DAMGE, C
    MICHEL, C
    APRAHAMIAN, M
    COUVREUR, P
    [J]. DIABETES, 1988, 37 (02) : 246 - 251
  • [13] Spontaneous association of hydrophobized dextran and poly-β-cyclodextrin into nanoassemblies.: Formation and interaction with a hydrophobic drug
    Daoud-Mahammed, S.
    Ringard-Lefebvre, C.
    Razzouq, N.
    Rosilio, V.
    Gillet, B.
    Couvreur, P.
    Amiel, C.
    Gref, R.
    [J]. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2007, 307 (01) : 83 - 93
  • [14] Apolipoprotein A-I, cyclodextrins and liposomes as potential drugs for the reversal of atherosclerosis. A review
    Dass, CR
    Jessup, W
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2000, 52 (07) : 731 - 761
  • [15] Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
    des Rieux, Anne
    Fievez, Virginie
    Garinot, Marie
    Schneider, Yves-Jacques
    Preat, Veronique
    [J]. JOURNAL OF CONTROLLED RELEASE, 2006, 116 (01) : 1 - 27
  • [16] Cyclodextrins and carrier systems
    Duchêne, D
    Wouessidjewe, D
    Ponchel, G
    [J]. JOURNAL OF CONTROLLED RELEASE, 1999, 62 (1-2) : 263 - 268
  • [17] Cyclodextrins in targeting -: Application to nanoparticles
    Duchêne, D
    Ponchel, G
    Wouessidjewe, D
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (01) : 29 - 40
  • [18] Duchene D., 1987, Cyclodextrins and Their Industrial Uses, P211
  • [19] Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A
    El-Shabouri, MH
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 249 (1-2) : 101 - 108
  • [20] No inhibition of gastro-intestinal propulsion after propofol- or propofol/ketamine-N2O/O2 anaesthesia -: A comparison of gastro-caecal transit after isoflurane anaesthesia
    Freye, E
    Sundermann, S
    Wilder-Smith, OHG
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1998, 42 (06) : 664 - 669